Efficacy of Calcium Channel Blocker in the Secondary Prevention of Myocardial Infarction-Retrospective Analysis of the 10-Year Prognosis of Coronary Thrombolysis-Treated Patients-

Tani, Shigemasa; Watanabe, Ichiro; Nagao, Ken; Kikushima, Kimio; Watanabe, Kazuhiro; Anazawa, Takeo; Kawamata, Hirofumi; Tachibana, Eizo; Furuya, Shinichi; Sasanuma, Toshifumi; Kushiro, Toshio; Kanmatsuse, Katsuo

doi:10.1253/circj.68.853

Cited by 9 publications

(2 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Statin therapy has been reported to be effective in lowering both the yellow intensity of plaques 21 and serum MDA-LDL level. 22 The present data, however, could indicate that moderate statin therapy is insufficient for plaque stabilization, because the frequency of statin use with standard doses was not significantly associated with the elevation of serum MAD-LDL in the present study. We therefore consider that patients with elevated MDA-LDL need more intensive statin therapy.…”

Section: Discussioncontrasting

confidence: 79%

Malondialdehyde-Modified Low-Density Lipoprotein Is a Useful Marker to Identify Patients With Vulnerable Plaque

Tajika

Okamatsu

Takano

et al. 2012

Circ J

View full text Add to dashboard Cite

Section: Discussioncontrasting

confidence: 79%

Malondialdehyde-Modified Low-Density Lipoprotein Is a Useful Marker to Identify Patients With Vulnerable Plaque

Tajika

Okamatsu

Takano

et al. 2012

Circ J

View full text Add to dashboard Cite

“…To minimize the influence of PCI, only lesions at least 10 mm away from the PCI site were selected for the measurements. 6 The primary efficacy parameter of the percent plaque volume was calculated using the following equation: ∆ plaque volume = (plaque volume at 6 months − baseline plaque volume)/baseline plaque volume × 100. Two independent investigators who were unaware of the patients' clinical data were responsible for measuring all the vessel parameters.…”

Section: Ivus Studymentioning

confidence: 99%

Coronary Plaque Regression and Lifestyle Modification in Patients Treated With Pravastatin - Assessment Mainly by Daily Aerobic Exercise and an Increase in the Serum Level of High-Density Lipoprotein Cholesterol -

Tani

Nagao

Anazawa

et al. 2010

Circ J

Self Cite

View full text Add to dashboard Cite

Background:The purpose of this study was to explore the effect of lifestyle modification, mainly daily aerobic exercise, on coronary atherosclerosis in patients with coronary artery disease (CAD). Methods and Results:A 6-month prospective observational study was conducted with 84 CAD patients receiving pravastatin treatment in order to evaluate the relationship between lifestyle modification, in particular aerobic exercise, and plaque volume as assessed by intravascular ultrasound (IVUS). Lifestyle during the study period was assessed by the-lifestyle modification score. A significant decrease in plaque volume by 12.9% was observed after 6 months of pravastatin therapy (P<0.0001 vs baseline). The change in plaque volume correlated with the change in the serum level of high-density lipoprotein cholesterol (HDL-C) (r=−0.549, P<0.0001), non-HDL-C (r= 0.248, P=0.03), low-density lipoprotein cholesterol/HDL-C (r=0.505, P<0.0001), apolipoprotein (apo) A-1 (r=−0.335, P=0.007) and apoB/apoA-1 (r=0.335, P=0.007), and lifestyle modification score (r=−0.616, P<0.0001). There was a clear positive correlation between a change in the serum HDL-C level and lifestyle modification score. Multivariate regression analysis revealed that the increase in serum HDL-C level and lifestyle modification score were independent predictors of coronary plaque regression. Conclusions:An appropriate combination of statin therapy and lifestyle modification, in particular, physical activity, may result in coronary plaque regression. This combined treatment strategy, inducing an increase of the serum HDL-C, may contribute to coronary plaque regression. (Circ J 2010; 74: 954 - 961)

show abstract

Association of blood pressure in the first-week of hospitalization and long-term mortality in patients with acute left ventricular myocardial infarction

Tang

Liu

Shi

et al. 2022

International Journal of Cardiology

View full text Add to dashboard Cite

Efficacy of Calcium Channel Blocker in the Secondary Prevention of Myocardial Infarction-Retrospective Analysis of the 10-Year Prognosis of Coronary Thrombolysis-Treated Patients-

Cited by 9 publications

References 35 publications

Malondialdehyde-Modified Low-Density Lipoprotein Is a Useful Marker to Identify Patients With Vulnerable Plaque

Malondialdehyde-Modified Low-Density Lipoprotein Is a Useful Marker to Identify Patients With Vulnerable Plaque

Coronary Plaque Regression and Lifestyle Modification in Patients Treated With Pravastatin - Assessment Mainly by Daily Aerobic Exercise and an Increase in the Serum Level of High-Density Lipoprotein Cholesterol -

Association of blood pressure in the first-week of hospitalization and long-term mortality in patients with acute left ventricular myocardial infarction

Contact Info

Product

Resources

About